INGN Q2 2022 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$103M+1.8% YoY

Gross Profit

$46M44.7% margin

Operating Income

-$3M-2.8% margin

Net Income

-$3M-3.3% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+28.6%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$355,000

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$470M

Total Liabilities

$114M

Stockholders' Equity

$357M

Cash & Equivalents

$224M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$103M	$102M	+1.8%
Gross Profit	$46M	$50M	-8.1%
Operating Income	-$3M	$12M	-124.6%
Net Income	-$3M	$5M	-167.5%

Geographic Segments

UNITED STATES

$66M64%

Non-US

$37M36%